We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Meconium Microbiome Can Help Predict Risk of Developing Allergies

By LabMedica International staff writers
Posted on 12 May 2021
Print article
Image: Schematic diagram of a rich meconium metabolome in human infants is associated with early-life gut microbiota composition and reduced allergic sensitization (Photo courtesy of University of British Columbia)
Image: Schematic diagram of a rich meconium metabolome in human infants is associated with early-life gut microbiota composition and reduced allergic sensitization (Photo courtesy of University of British Columbia)
Meconium, which is typically passed within the first day of life, is made up of a variety of materials ingested and excreted during development, ranging from skin cells, amniotic fluid and various molecules known as metabolites.

Microbiota maturation begins in earnest immediately after birth, when pioneering bacteria are introduced into the neonatal gut and form a niche capable of supporting successive colonizers that will comprise the infant microbiota. Maturation of this microbial community continues through the first few years of life and occurs concomitantly with dramatic shifts in host immune function.

A team of scientists from the University of British Columbia (Vancouver, BC, Canada) analyzed meconium samples from 37 healthy control infants and 63 atopy infants enrolled in the CHILD Cohort Study (CHILD), a world-leading birth cohort study in maternal, newborn and child health studies. These samples were analyzed by Metabolon, Inc (Morrisville, NC, USA) for non-targeted metabolic profiling via their mView Global Metabolomics Profiling Platform using Ultrahigh Performance Liquid Chromatography-Tandem Mass Spectroscopy (UPLC-MS/MS).

The scientists discovered that the fewer different types of molecules a baby's meconium contained, the greater the child's risk of developing allergies by one year. They also found that a reduction in certain molecules was associated with changes to key bacterial groups. These bacteria groups play a critical role in the development and maturation of a vast ecosystem of gut microbes, known as the microbiota, which is a powerful player in health and disease. Using a machine-learning algorithm, the scientists combined meconium, microbe and clinical data to predict with a high degree of accuracy (76%), and more reliably than ever before, whether or not an infant would develop allergies by one year of age.

Stuart E. Turvey, MBBS, DPhil, FRCPC, a Professor of Pediatrics and the senior author of the study, said, “We know that children with allergies are at the highest risk of also developing asthma. Now we have an opportunity to identify at-risk infants who could benefit from early interventions before they even begin to show signs and symptoms of allergies or asthma later in life.” The study was published on April 29, 2021 in the journal Cell Reports Medicine.

Related Links:
University of British Columbia
Metabolon, Inc


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.